An impedimetric vascular endothelial growth factor biosensor-based PAMAM/cysteamine-modified gold electrode for monitoring of tumor growth

Analytical Biochemistry

Volumn 423, Issue 2, 2012, Pages 277-285

  Sezgintürk, Mustafa Kemal ^a   Uygun, Zihni Onur ^b  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

Author keywords

Biosensor; Electrochemical impedance spectroscopy; PAMAM; Tumor growth; VEGF; VEGF R1

Indexed keywords

DENDRIMERS; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTRODES; GOLD; TUMORS;

GLUTARALDEHYDE CROSS-LINKING; IMMOBILIZATION CONDITIONS; PAMAM; TUMOR GROWTH; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; VEGF; VEGF-R1;

BIOSENSORS;

DENDRIMER; GLUTARALDEHYDE; GOLD; MERCAPTAMINE; POLYAMIDOAMINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; BIOSENSOR; BREAST CANCER; CROSS LINKING; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTRODE; HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SPECTROSCOPY; TUMOR GROWTH;

EID: 84859009441     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.12.049     Document Type: Article

References (45)

1. J. Sjostrom, C. Blomqvist, P. Heikkila, K.V. Bogulawski, A. Raiseanen-Sokolowski, N.O. Bengtsson, I. Mjaaland, P. Malmstron, B. Ostenstadt, J. Berg, E. Wist, V. Valvere, E. Saksela, Predictive value of p53 mdm-2, p21 and mib-1 for chemotherapy response in advanced breast cancer, Clin. Cancer Res. 6 (8) (2000) 3103-3110. (Pubitemid 30637734)
2. G. Laguens, S. Coronato, W. Di Girolamo, Biomarkers in breast cancer, Cent. Eur. J. Med. 4 (1) (2006) 330-347. (Pubitemid 44876494)
3. V. Kulasingam, E.P. Diamandis, Tissue culture-based breast cancer biomarker discovery platform, molecular regulation of vessel maturation, Int. J. Cancer 123 (9) (2008) 2007-2012.
4. R.K. Jain, Molecular regulation of vessel maturation, Nat. Med. 9 (6) (2003) 685-693. (Pubitemid 36749217)
5. N. Ferrara, H.P. Gerber, J. LeCouter, The biology of VEGF and its receptors, Nat. Med. 9 (6) (2003) 669-676. (Pubitemid 36749215)
6. D. Hanahan, J. Folkman, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell 86 (3) (1996) 353-364. (Pubitemid 26272076)
7. C.L. Sawyers, The cancer biomarker problem, Nature 452 (2008) 548-552. (Pubitemid 351483368)
8. P. Wang, J.R. Whiteaker, A.G. Paulovich, The evolving role of mass spectrometry in cancer biomarker discovery, Cancer Biol. Ther. 8 (12) (2009) 1083-1094.
9. P. Boffetta, Exploring a cancer biomarker: the example of C-reactive protein, J. Natl. Cancer Inst. 102 (3) (2010) 142-143.
10. A. Sidoni, G.A. Cavalieri, G. D'Amico, G. Brachelente, E. Bucchiarelli, Biopathological significance of single cell DNA aneuploidy measured by static cytometry in breast cancer, Breast 10 (2001) 325-329. (Pubitemid 32694510)
11. B. Linderholm, K. Grankvist, N. Wilking, M. Johansson, B. Tavelin, R. Henriksson, Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment, J. Clin. Oncol. 18 (7) (2000) 1423-1431. (Pubitemid 30205387)
12. A. Gown, S.E. Rivskin, H.N. Hunt, N.L. Polissar, S.C. Davies, M.K. Atwood, R.J. Tickman, M. Mickel, Prognostic factor of vascular endothelial growth factor (VEGF) expression in node-positive breast cancer, Proc. Am. Soc. Clin. Oncol. 20 (2001) 1703 (abstract).
13. J.A. Foekens, H.A. Peters, N. Grebenchtchikov, M.P. Look, M.E. Meijer-van Gelder, A. Geurts-Moespot, T.H. van der Kwast, C.G.J. Sweep, J.G.M. Klijn, High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer, Cancer Res. 61 (14) (2001) 5407-5414. (Pubitemid 32694919)
14. J. Adams, P.J. Carder, S. Downey, M.A. Forbes, K. MacLennan, V. Allgar, S. Kaufman, S. Hallam, R. Bicknell, J.J. Walker, F. Cairnduff, P.J. Selby, T.J. Perren, M. Lansdown, R.E. Banks, Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum and tissue VEGF and microvessel density and effects of tamoxifen, Cancer Res. 60 (2000) 2898-2905. (Pubitemid 30395813)
15. R.S. Rampaul, S.E. Pinder, R.I. Nicholson, W.J. Gullick, J.F. Robertson, I.O. Ellis, Clinical value of epidermal growth factor receptor expression in primary breast cancer, Adv. Anat. Pathol. 12 (2005) 271-273. (Pubitemid 41463808)
16. H.W. Lo, S.C. Hsu, M.C. Hung, EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization, Breast Cancer Res. Treat. 28 (2005) 1-8.
17. H. Rochefort, M. Garcia, M. Glondu, V. Laurent, E. Liaudet, J. Rey, P. Roger, Cathepsin d in breast cancer: mechanisms and clinical applications a 1999 Overview, Clin. Chim. Acta 291 (2000) (1999) 157-170.
18. V.V. Levenson, Biomarkers for early detection of breast cancer: what, when, and where?, Biochim Biophy. Acta 1770 (2007) 847-856. (Pubitemid 46617032)
19. R.A. Oldenburg, H. Meijers-Heijboer, C.J. Cornelisse, P. Devilee, Genetic susceptibility for breast cancer: how many more genes to be found?, Crit Rev. Oncol. Hematol. 63 (2007) 125-149. (Pubitemid 46990913)
20. H.R. Byon, H.C. Choi, Network single-walled carbon nanotube-field effect transistors (SWNT-FETs) with increased Schottky contact area for highly sensitive biosensor applications, J. Am. Chem. Soc. 128 (2006) 2188-2189.
21. Y. Cui, Q. Wei, H. Park, C.M. Lieber, Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species, Science 293 (17) (2001) 1289-1292. (Pubitemid 32777412)
22. Z. Gao, A. Agarwal, A.D. Trigg, N. Singh, C. Fang, C.-H. Tung, Y. Fan, K.D. Buddharaju, J. Kong, Silicon nanowire arrays for label-free detection of DNA, Anal. Chem. 79 (2007) 3291-3297. (Pubitemid 46717159)
23. J. Hahm, C.M. Lieber, Direct ultrasensitive electrical detection of DNA and DNA sequence variations using nanowire nanosensors, Nano Lett. 4 (2004) 51-54. (Pubitemid 38167862)
24. A. Kim, C.S. Ah, H.Y. Yu, J.-H. Yang, I.-B. Baek, C.-G. Ahn, C.W. Park, M.S. Jun, S. Lee, Ultrasensitive, label-free, and real-time immunodetection using silicon field-effect transistors, Appl. Phys. Lett. 91 (2007) 103901-103903.
25. F. Patolsky, G. Zheng, O. Hayden, M. Lakadamyali, X. Zhuang, C.M. Lieber, Electrical detection of single viruses, Proc. Natl. Acad. Sci. USA 101 (2004) 14017-14022. (Pubitemid 39305021)
26. E. Stern, J.F. Klemic, D.A. Routenberg, P.N. Wyrembak, D.B. Turner-Evans, A.D. Hamilton, D.A. LaVan, T.M. Fahmy, M.A. Reed, Label-free immunodetection with CMOS-compatible semiconducting nanowires, Nature 445 (2007) 519-522. (Pubitemid 46197629)
27. H.-S. Lee, K.S. Kim, C.-J. Kim, S.K. Hahn, M.H. Jo, Electrical detection of VEGFs for cancer diagnoses using anti-vascular endothelial growth factor aptamer modified Si nanowire FETs, Biosens. Bioelectron. 24 (6) (2009) 1801-1805.
28. S. Prabhulkar, S. Alwarappan, G. Liu, C.-Z. Li, Amperometric microimmunosensor for the detection of tumor biomarker, Biosens. Bioelectron. 24 (12) (2009) 3524-3530.
29. A.W. Bott, Electrochemical techniques for the characterization of redox polymers, Curr. Sep. 19 (2001) 71-75.
30. E. Katz, I. Willner, Probing biomolecular interactions at conductive and semiconductive surfaces by impedance spectroscopy: routes to impedimetric immunosensors, DNA sensors and enzyme biosensors, Electroanalysis 15 (2003) 913-947.
31. J.G. Guan, Y.Q. Miao, Q.J. Zhang, Impedimetric biosensors, J. Biosci. Bioeng. 97 (4) (2004) 219-226.
32. M. Shibuya, S. Yamaguchi, A. Yamane, T. Ikeda, A. Tojo, H. Matsushime, M. Sato, Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family, Oncogene 5 (4) (1990) 519-524.
33. R.L. Kendall, K.A. Thomas, Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor, Proc. Natl. Acad. Sci. USA 90 (22) (1993) 10705-10709. (Pubitemid 23347111)
34. G. Neufeld, T. Cohen, S. Gengrinovitch, Z. Poltorak, Vascular endothelial growth factor (VEGF) and its receptors, FASEB J. 13 (1) (1999) 9-22. (Pubitemid 29038270)
35. Y. He, S.K. Smith, K.A. Day, D.E. Clark, D.R. Licence, D.S. Charnock-Jones, Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity, Mol. Endocrinol. 13 (4) (1999) 537-545. (Pubitemid 30636421)
36. B. Olofsson, E. Korpelainen, M.S. Pepper, S.J. Mandriota, K. Aase, V. Kumar, Y. Gunji, M.M. Jeltsch, M. Shibuya, K. Alitalo, U. Eriksson, Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells, Proc. Natl. Acad. Sci. USA 95 (20) (1998) 11709-11714. (Pubitemid 28460479)
37. G. Conn, D.D. Soderman, M.T. Schaeffer, M. Wile, V.B. Hatcher, K.A. Thomas, Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line, Proc. Natl. Acad. Sci. USA 87 (4) (1990) 1323-1327.
38. L. Alfonta, E. Katz, I. Willner, Sensing of acetylcholine by a tricomponentenzyme layered electrode using faradaic impedance spectroscopy, cyclic voltammetry, and microgravimetric quartz crystal microbalance transduction methods, Anal. Chem. 72 (2000) 927-935. (Pubitemid 30127397)
39. A.J. Bard, L.R. Faulkner, Electrochemical Methods: Fundamentals and Applications, Wiley, New York, 2001.
40. R.de.L. Kronig, On the theory of dispersion of X-rays, J. Opt. Soc. Am. Rev. Sci. Inst. 12 (1926) 547-557.
41. H.A. Kramers, Die dispersion und absorption von Rontgenstrahlen, Phys. Z. 30 (1929) 522-523.
42. M.E. Orazem, B. Tribollet, Electrochemical Impedance Spectroscopy, Wiley, NJ, 2008.
43. Q.-A. Huang, R. Hui, B. Wang, J. Zhang, A review of AC impedance modeling and validation in SOFC diagnosis, Electrochim. Acta 52 (2007) 8144-8164. (Pubitemid 47304435)
44. W. Ehm, H. Gohr, R. Kaus, B. Roseler, C.A. Schiller, The evaluation of electrochemical impedance spectra using a modified logarithmic Hilbert transform, ACH-Models Chem. 137 (2000) 145-157.
45. B.A. Boukamp, A linear Kronig-Kramers transform test for immittance data validation, J. Electrochem. Soc. 142 (1995) 1885-1894.